QA: Kronos Bio Inc in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001741830_2022_Kronos_Bio_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001741830, Kronos Bio Inc

  xvar xval
0 AssetsCurrent 347,554,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 43,922,000
4 LiabilitiesCurrent 13,626,000
5 LiabilitiesNoncurrent 32,753,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 38,495,000
9 ResearchAndDevelopmentExpense 112,903,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 320,000
13 remainder_ComprehensiveNetIncome -20,000
  yvar yval
0 Assets 391,476,000
1 Liabilities 46,379,000
2 Expenses 151,398,000
3 Revenues 0
4 StockholdersEquity 345,097,000
5 NetIncome -151,078,000
6 ComprehensiveNetIncome -151,088,000
7 BaseVar 294,796,500
8 EconomicCapitalRatiobeforeLimitedLiability 2.75
9 EconomicCapitalRatio 3.52

Edgar->Model Mapping

Feature Distribution

Change over Time